| Drug Name | Janssen COVID-19 Vaccine |
|---|---|
| Drug Class | |
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) | |
| Risk |
COVID-19 Vaccine Janssen: Risk for immune thrombocytopenia (ITP) and venous thromboembolism (VTE) |
| Dear Healthcare provider letter DHPC |
|